The University of Toledo college of medicine and another Ohio medical school will use $3 million in state funding to establish a center to study, develop, and commercialize drugs to treat disorders of the immune system, such as rheumatoid arthritis, asthma, and lupus, UT announced yesterday.
The former Medical College of Ohio will use $2.08 million of $3 million from the Ohio Third Frontier Program to renovate and add both laboratory and office space for two research scientists to be recruited by UT.
It also will get a next-generation mass spectrometer for proteomics research.
Case Western Reserve University school of medicine will receive $920,000 of the funding to create an interactive video conference facility.
Both universities are required to provide matching funds for the center, to be called the Ohio Center for Innovative Immunosuppressive Therapeutics.